CAS 303957-69-9

Formel: C20H31NO4

InChl: InChI=1S/C20H31NO4/c1-5-6-7-8-9-10-11-12-17(23)21-16(13-14(2)3)19(24)18(15(4)22)20(21)25/h11-12,14,16,24H,5-10,13H2,1-4H3/b12-11+/t16-/m1/s1

InChI Key: GNGSBVNLHSNSDF-LPQFERQCSA-N

SMILES: CCCCCCC/C=C/C(=O)N1[C@@H](C(=C(C1=O)C(=O)C)O)CC(C)C

Reutericyclin

CAS: 303957-69-9

Reutericyclin

Molekulargewicht: 349.23

Ref: 10-F557022

Reutericyclin

CAS: 303957-69-9

Reutericyclin

Formel: C₂₀H₃₁NO₄

Reinheit: 95.15%

Molekulargewicht: 349.46

Ref: 54-OR1114999

Reutericyclin

CAS: 303957-69-9

Reutericyclin is an oral anti-Gram-positive compound with antibacterial and anti-obesity effects regulating intestinal flora.

Formel: C₂₀H₃₁NO₄

Reinheit: 98%

Farbe und Form: Solid

Molekulargewicht: 349.4644

Ref: TM-T12712

Reutericyclin

CAS: 303957-69-9

Formel: C₂₀H₃₁NO₄

Reinheit: 95.15%

Molekulargewicht: 349.4644

Ref: IN-DA00BJH7

Reutericyclin

CAS: 303957-69-9

Reutericyclin is a novel antibiotic that inhibits fatty acid synthesis. It has been shown to be effective against oral pathogens and microbial infections. Reutericyclin has been shown to inhibit the growth of bacteria by binding to the bacterial fatty acid synthase, which is an enzyme that catalyzes the first step in the biosynthesis of fatty acids. The drug also binds to ATP synthase, preventing the production of ATP, which is needed for bacterial cell division. Reutericyclin has been shown to have antimicrobial properties in both model systems and humans, but it does not have any significant side effects on humans or animals.

Formel: C₂₀H₃₁NO₄

Reinheit: Min. 95%

Farbe und Form: Powder

Molekulargewicht: 349.5 g/mol

Ref: 3D-DMA95769